Eris Lifesciences share news and announcements
NSE: ERISBSE: 540596Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹1,121.20.
- Next results date: the board meets on 26 Oct 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹15,199 Cr353rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 29 Jul 2026
- 23.6
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 20 May 2026
- 3.9
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.66%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 29 Jul 2026
- 19.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 29 Jul 2026
- 13.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 20 May 2026
- 0.59
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 37,94348.8% delivered
Eris Lifesciences share news and announcements
808 announcements, routine notices left out, newest first. Page 6 of 17.
Jul 2023
5 Jul · Analysts
Jun 2023
14 Jun · Updates
May 2023
29 May · Analysts
29 May · Analysts
17 May · Rating
17 May · Board meeting
12 May · Analysts
5 May · Rating
Apr 2023
24 Apr · Analysts
17 Apr · Analysts
12 Apr · Analysts
10 Apr · Disclosure
10 Apr · Analysts
6 Apr · Analysts
4 Apr · Analysts
3 Apr · Analysts
Mar 2023
27 Mar · Analysts
24 Mar · Business
20 Mar · Analysts
16 Mar · Analysts
16 Mar · Business
2 Mar · Disclosure
Feb 2023
28 Feb · Analysts
15 Feb · Analysts
14 Feb · Analysts
9 Feb · Analysts
Jan 2023
19 Jan · Analysts
17 Jan · Business
17 Jan · Board meeting
14 Jan · Analysts
4 Jan · Analysts
Dec 2022
20 Dec · Analysts
Nov 2022
18 Nov · General updates
4 Nov · Related Party Transaction
3 Nov · General updates
Oct 2022
13 Oct · Legal
The exchange asked on 13 Oct 2022